Since IL-15 is produced by a vast diversity of cells in vivo, we can postulate that endogenous IL-15 is presented by IL-15Rα harbored by Dex leading to significant NK cell proliferation in vivo after Dex vaccination (Fig. 3) and NKG2D restoration in melanoma patients (Fig. 5). This evidence concerns the gene KLRK1 and melanoma.